Amerise Biosciences Limited (BOM:531681)

Amerise Biosciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	0.22	0.21	0.14	0.13	0.19
Cash & Short-Term Investments	0.22	0.21	0.14	0.13	0.19
Cash Growth	5.21%	55.15%	4.61%	-32.69%	-23.13%
Accounts Receivable	-	-	-	62.17	-
Receivables	-	-	-	62.17	-
Other Current Assets	0.05	0.02	-	-0	-
Total Current Assets	0.27	0.23	0.14	62.29	0.19
Long-Term Investments	23.81	22.65	45.66	46.91	30.41
Other Long-Term Assets	-	-	-	-0	-
Total Assets	84.63	53.9	56.47	119.88	56.28
Accounts Payable	-	-	-	62.66	4.8
Other Current Liabilities	30.84	0.16	0.37	0.01	0.57
Total Current Liabilities	30.84	0.16	0.37	62.67	5.38
Long-Term Debt	-	-	0.9	0.83	-
Other Long-Term Liabilities	-	-	-	-0	-
Total Liabilities	30.84	0.16	1.27	63.49	5.38
Common Stock	66.07	66.07	66.07	66.07	66.07
Retained Earnings	-	-13.14	-11.68	-10.49	-15.98
Comprehensive Income & Other	-12.27	0.81	0.81	0.81	0.81
Shareholders' Equity	53.8	53.74	55.2	56.39	50.9
Total Liabilities & Equity	84.63	53.9	56.47	119.88	56.28
Total Debt	-	-	0.9	0.83	-
Net Cash (Debt)	0.22	0.21	-0.76	-0.7	0.19
Net Cash Growth	5.21%	-	-	-	-23.13%
Net Cash Per Share	0.00	0.00	-0.01	-0.01	0.00
Filing Date Shares Outstanding	52.95	66.07	66.07	66.07	66.07
Total Common Shares Outstanding	52.95	66.07	66.07	66.07	66.07
Working Capital	-30.57	0.07	-0.23	-0.37	-5.19
Book Value Per Share	1.02	0.81	0.84	0.85	0.77
Tangible Book Value	53.8	53.74	55.2	56.39	50.9
Tangible Book Value Per Share	1.02	0.81	0.84	0.85	0.77

Source: S&P Global Market Intelligence. Standard template. Financial Sources.